Dr. Noel García Medel

Noel García Medel, Ph.D. is Cofounder and Chief Scientific Officer at SimCosmetic Biotech, Cofounder and Scientific Managing Director at Innovative Health Group, and Postdoctoral Researcher University of Códoba. His working field is Artificial Intelligence applied to Life Sciences and he has extensive experience in the use of public databases.
 
His papers include Functional Interaction of the Ankylosing Spondylitis-associated Endoplasmic Reticulum Aminopeptidase 1 Polymorphism and HLA-B27 in Vivo, Peptide Handling by HLA-B27 Subtypes Influences Their Biological Behavior, Association with Ankylosing Spondylitis and Susceptibility to Endoplasmic Reticulum Aminopeptidase 1 (ERAP1), β-arrestin-1 mediates the TCR-triggered re-routing of distal receptors to the immunological synapse by a PKC-mediated mechanism, The Origin of Proteasome-inhibitor Resistant HLA Class I Peptidomes: a Study With HLA-A*68:01, and Presentation of Cytosolically Stable Peptides by HLA-B27 Is Not Dependent on the Canonic Interactions of N-Terminal Basic Residues in the A Pocket.
 
Noel earned his Ph.D. in Biomedical/Medical Engineering at Autonomous University of Madrid in 2012; his Master’s degree in Biophysics, Biomedical/Medical Engineering at Autonomous University of Madrid in 2005; and his Bachelor’s degree in Biochemistry at Complutense University of Madrid in 2003.
 
View his ResearchGate page. Read his LinkedIn profile.